A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Propensity Score-Matched Analysis

Carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB), an important nosocomial pathogen, occurs particularly in the intensive care unit (ICU). Thus, the aim of this study was to compare the efficacy and safety of documented treatment with colistin monotherapy versus colistin plus meropenem in c...

Descripción completa

Detalles Bibliográficos

Autores principales:	Wasan Katip, Suriyon Uitrakul, Peninnah Oberdorfer
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2020-09-01
Colección:	Antibiotics
Materias:	critically ill patients combination therapy colistin meropenem carbapenem-resistant <i>Acinetobacter baumannii</i>
Acceso en línea:	https://www.mdpi.com/2079-6382/9/10/647
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!